AIChE and the Society for Biological Engineering join forces with Wiley to launch "Bioengineering & Translational Medicine," with Samir Mitragotri of the University of California, Santa Barbara, as editor-in-chiefOctober 15, 2015 Share The American Institute of Chemical Engineers (AIChE) and its Society for Biological Engineering (SBE), in partnership with John Wiley and Sons, are launching a new quarterly, peer-reviewed, online, open-access journal, "Bioengineering & Translational Medicine," in 2016. To be part of the Wiley Open Access portfolio and edited by Samir Mitragotri of the University of California, Santa Barbara, the new journal will focus on ways chemical and biological engineering are driving innovations and solutions that impact clinical practice and commercial healthcare products. The journal will also highlight scientific and technical breakthroughs currently in the process of clinical and commercial translation. In announcing "Bioengineering & Translational Medicine," AIChE Executive Director June Wispelwey said that the new journal represents “one of the latest and most significant examples of the strengths that chemical and biological engineers bring to the frontiers of inter-disciplinary research and its application.” She added that she was excited that the journal attracted “such an esteemed editor in Dr. Mitragotri, and a very, very distinguished editorial advisory board.” In discussing his plans for the journal, Mitragotri said, “Converting engineering advances into useful clinical products is a major challenge that requires attention to issues such as safety, manufacturability, regulatory hurdles, cost, and patient acceptance, among others.” These issues, he pointed out, are not typically considered in fundamental academic research. “Clinical translation also often needs concurrent consideration of commercial translation, with the team and the resources required for clinical translation often assembled during commercial translation,” he explained. He added that this interplay presents its own set of challenges. "Bioengineering & Translational Medicine" welcomes manuscripts that provide new insights into translational hurdles, as well as examples of technologies that have demonstrated progress toward clinical or commercial translation. It invites contributions on topics including, but not limited to, drug delivery, drug discovery, tissue engineering, synthetic biology, gene therapy, computational modeling and bioinformatics, among others. (A more comprehensive list of topics can be found in the journal’s statement of scope.) The journal will include research reports, reviews, and rapid communications. Fully open access "Bioengineering & Translational Medicine" will be published under CC-BY license. Mitragotri concluded: “To researchers who are active, or aspiring to be active, in clinical and commercial translation of biological technologies, I say ‘this is your journal.’ With a stellar advisory board behind us, we are poised for an exciting, quick, and successful launch. We promise a rapid and fair review and fast publication. We also welcome your suggestions and comments on ways we can make the journal better serve your needs.” Readership will include chemical engineers; biological engineers, biomolecular engineers, biomedical engineers and other engineers and scientists with interests in translational medicine, biotechnology, and biochemical and biomolecular engineering; and physicians and other healthcare researchers and professionals. Additional information is available at: http://www.aiche.org/biotm or by email at firstname.lastname@example.org. Download press releaseAbout SBE: Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. http://bio.aiche.org. About AIChE: Founded in 1908, AIChE is a professional society of more than 50,000 chemical engineers in 100 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nanotechnology and chemical plant safety and security. More information about AIChE is available at www.aiche.org. About WILEY: Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The Company’s website can be accessed at www.wiley.com.